TP53 and rhabdomyolysis: As pretreatment of pifithrin-α decreased p53 phosphorylation and creatine kinase more effectively and combined with relatively mild rhabdomyolysis and AKI, so it was superior to pifithrin-α rescue therapy in ameliorating rhabdomyolysis and related AKI.